Is a complete NDRA research report available?

No complete published report is available for ENDRA Life Sciences Inc. (NDRA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · USD

$4.86

-0.37 (-7.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NDRA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.2M
Net income (ttm)	-7.3M
EPS (ttm)	-$7.71
Shares out	1.3M
Volume	7,652.314
Beta	-0.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.3M
EPS (ttm): -$7.71
Market cap: 6.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NDRA indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001681682
Company name	ENDRA Life Sciences Inc.
Country	United States
Country code	US
Cusip	29273B500
Employees	11
Employees Change	-5%
Employees Change Percent	-31.25
Enterprise value	$6.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	42.85
Industry PE Fwd	26.1
IPO Date	2017-05-09
Isin	US29273B5003
Last refreshed	2026-07-25
Market cap	$6.2M
Market cap category	Nano-Cap
Price	$4.86
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	3845
Symbol	NDRA
Website	https://endrainc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-118.31%
FCF yield	-81.15%
P/B ratio	3.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.3M
Net Income Growth Years	1%
Profit Per Employee	$-663,865
ROA	-122.3
Roa5y	-86.02
ROCE	-248.5
ROE	-412.6
Roe5y	-199.9
ROIC	-176.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.68%
Cagr3y	-87.28%
Cagr5y	-85.04%
EPS Growth Quarters	1
EPS Growth Years	6
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$3.4M
Cash	$356,462
Current Assets	$536,666
Current Liabilities	$835,440
Debt	$461,206
Debt Equity	$0.26
Equity	$1.8M
Liabilities	$1.7M
Long Term Assets	$2.9M
Long Term Liabilities	$815,857
Net Cash	$-104,744
Net Cash By Market Cap	$-1.7
Net Debt Equity	$0.06
Tangible Book Value	$1.8M
Tangible Book Value Per Share	$1.44
WACC	3.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.64
Net Working Capital	$-521,283
Quick ratio	0.43
Working Capital	$-298,774

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-178.72%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.67%
200-day SMA	4.93
3Y total return	-99.79%
50-day SMA	5.11
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.99%
All Time High	205,800.2
All Time High Change	-100%
All Time High Date	2017-12-26
All Time Low	2.9
All Time Low Change	67.59%
All Time Low Date	2025-05-09
ATR	0.57
Beta	-0.05
Beta1y	3.48
Beta2y	1.26
Ch YTD	7.29
High	5.19
High52	9.85
High52 Date	2025-10-13
High52ch	-50.66%
Low	4.86
Low52	2.96
Low52 Date	2026-03-10
Low52ch	64.19%
Ma50ch	-4.93%
Premarket Change Percent	-4.4
Premarket Price	$5
Premarket Volume	242
Price vs 200-day SMA	-1.48%
RSI	46.16
RSI Monthly	31.69
RSI Weekly	46.42
Sharpe ratio	0.18x
Sortino ratio	0.31
Total Return	-178.72%
Tr YTD	7.29
Tr1m	-8.47%
Tr1w	-2.61%
Tr3m	-2.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.84
Operating Income	$-6.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,199,163%
Float Percent	94.42%
Shares Insiders	5.58%
Shares Institutions	7.06%
Shares Out	1,270,077
Shares Qo Q	8.03%
Shares Yo Y	178.72%
Short Float	3.51%
Short Ratio	0.9
Short Shares	3.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.8M
Average Volume	36,888.3x
Bv Per Share	1.44
Ch1m	-8.47
Ch1w	-2.61
Ch1y	-29.67
Ch3m	-2.8
Ch3y	-99.79
Ch5y	-99.99
Ch6m	9.21
Change	-7.07%
Change From Open	-4.89
Close	5.23
Days Gap	-2.29
Depreciation Amortization	39,751
Dollar Volume	37,190.2
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-6.5M
EBITDA	$-6.4M
EPS	$-7.71
F Score	1
FCF	$-5M
FCF EV Yield	-79.8x
FCF Per Share	$-3.94
Financing CF	5,850,667
Fiscal Year End	December
Founded	2,007
Investing CF	-2,550,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-18
Last Report Date	2026-03-31
Last Split Date	2024-11-07
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	4.63
Ma150ch	4.92%
Ma20	5.18
Ma20ch	-6.18%
Net CF	-1,708,412
Next Earnings Date	2026-08-13
Open	5.11
Optionable	No
Position In Range	0
Ppne	464,749
Pre Close	5.23
Price Date	2026-07-24
Ptbv Ratio	3.45
Relative Volume	0.21x
Share Based Comp	820,814
Tr6m	9.21%
Us State	Michigan
Volume	7,652.3

ENDRA Life Sciences Inc. (NDRA)

Coverage state: Market snapshot only — no published research

Generate the first NDRA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NDRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NDRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NDRA

Frequently asked questions